Back
Product details:
CAS
500-38-9
Purity
95%
Nordihydroguaiaretic acid inhibits leukotriene B4 (LTB4) formation in human polymorphonuclear leukocytes mediated by 5-lipoxygenase with IC50 = 85 nM; for 5-lipoxygenase from rat basophilic leukemia (RBL-1) cells IC50 = 10 nM. It also inhibits cholinesterase (IC50= 0.78nM) and carbonic anhydrase 2 (Ki = 2.56 nM), carbonic anhydrase 1 (Ki = 2.81 nM)
Properties
Name
Nordihydroguaiaretic acid
Smiles
CC(CC=1C=CC(O)=C(O)C1)C(C)CC=2C=CC(O)=C(O)C2
Targets
Please log in to see this information
SDS
2,3-dimethyl-1,4-bis-[3,4-dihydroxyphenyl]-butane | 4,4'-(2,3-dimethylbutane-1,4-diyl)dibenzene-1,2-diol | 4,4'-(2,3-dimethyltetramethylene)dipyrocatechol | NDGA | NGDA | masoprocol | nordihydroguaiaretic acid | nordihydroguairetic acid | nordihydrogualaretic acid | nordihydroguaretic acid
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$50
2 mg
$52
5 mg
$53
10 mg
$62
15 mg
$67
20 mg
$72
25 mg
$80
30 mg
$88
35 mg
$96
40 mg
$104
45 mg
$112
50 mg
$120
75 mg
$140
100 mg
$150
Quantity
1
Total amount
$ 53
2,3-dimethyl-1,4-bis-[3,4-dihydroxyphenyl]-butane | 4,4'-(2,3-dimethylbutane-1,4-diyl)dibenzene-1,2-diol | 4,4'-(2,3-dimethyltetramethylene)dipyrocatechol | NDGA | NGDA | masoprocol | nordihydroguaiaretic acid | nordihydroguairetic acid | nordihydrogualaretic acid | nordihydroguaretic acid
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.